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Background: CABG is based on the principles of: 1) coronary angiography for the anatomic (A) roadmap; 2) the % A stenosis as the trigger for 
grafting an epicardial coronary artery (ECA); 3) complete revascularization; and 4) technical success (patent anastomosis and graft) and clinical 
stability as the intraoperative outcomes. In multivessel disease pts, A-based revascularization in SYNTAX yielded better long-term outcomes with 
CABG than PCI, while functional (F)-based PCI revascularization in FAME and DEFER was superior to A-based PCI. We used a new intraoperative 
imaging system to determine if F stenoses could be identified at CABG.
Methods: The SPY-Cardiac Complex Angiography and Perfusion system is a fluorescence near-infrared image technology. SPY-CCAP captures the 
complete arterial, microvascular and venous phases of angiography in each 34-sec image data sequence; regional myocardial perfusion (RMP) 
is assessed from the arterial + microvascular phase metadata. A post- vs pre-grafting image comparison quantifies the RMP change induced by a 
bypass graft, with per-graft regional and global 3-D displays in real time. 
Results: In CABG, a F stenosis in an ECA is associated with regional chronic stable angina (CSA) ischemia, which should then be relieved by the 
bypass graft. This relief of CSA ischemia can be indexed and quantified as the change in RMP. Using the SPY-CCAP data acquisition protocol in 86 
consecutive pts (48 off-pump and 38 on-pump), 156 grafts to ECAs (> 70% A stenosis) were analyzed for RMP quantification. CABG was performed in 
accordance with the 4 principles. All grafts were widely patent by arterial phase SPY angiography. However, 24% (21/88) of in-situ arterial grafts and 
18% (12/68) of SVGs showed minimal RMP increase, consistent with A stenoses (no CSA ischemia) despite the 70% trigger for grafting. 
Conclusions: F stenoses can be readily identified at CABG by quantification of the relief of CSA ischemia, if present. This identification of 
angiographically-patent bypass grafts that produce minimal change in RMP (A stenoses) suggests that knowledge about A and F stenoses in 
revascularization may be as important in CABG as it is in PCI.
